247 Market News: Independence Day May Come Early for Siyata Mobile SYTA Shareholders via $185M Core Gaming Merger
Core Gaming, renowned for a vast portfolio comprising over 2,100 games, has achieved over 790 million cumulative downloads, drawing a robust community of 43 million monthly active users (MAUs). Recently, Core Gaming introduced its innovative AI COMIC App, an advanced AI-powered visual content creation platform. The app has swiftly gained popularity, demonstrating robust monetization and strong user retention metrics.
The global AI gaming market is seeing explosive growth, with recent industry forecasts highlighting continued remarkable double digit growth rates:
Aitan Zacharin, CEO of Core Gaming and slated to lead the combined companies post merger, commented, 'With AI COMIC, we have developed a platform that puts studio-grade production capabilities into the hands of everyday users. AI COMIC empowers creators, whether they are gamers, artists or marketers, with AI tools that are not only powerful but also accessible. What once took weeks of planning, design and collaboration can now be accomplished in minutes, freeing creators to focus on their vision and storytelling. AI COMIC rapidly accelerates development, but importantly, it unlocks new forms of expression, removes friction and enables a broader, more diverse creative community to bring their ideas to life delivering results that rival professional studios.'
Upon Nasdaq approval, Siyata Mobile will retain a minimum of 10% equity interest in the combined entity for legacy shareholders, supported by a special dividend, underscoring its commitment to delivering sustained value.
This strategic acquisition not only places Siyata Mobile at the forefront of the booming AI gaming sector but also significantly enhances its revenue profile, Core Gaming's reported revenue grew from $13.2 million 2021, $38.9 million in 2022, $57.0 million in 2023, an estimated $80.8 million for 2024.
Readers are invited to view Aitan Zacharin's investor presentation, which confirmed strong growth across the board and Core Gaming's position as a formidable player in the rapidly growing mobile gaming market.
Core Gaming's growth is powered by its AI-based BI platform, which allows it to serve tailored ads and optimize revenue per user in real time and turn player engagement into reliable financial performance.
ValueScope, LLC., a Marshall & Stevens company that's considered the gold standard, raised its most recent Core Gaming valuation to over $185 million, partly based on Core Gaming's metrics.
ValueScope is projecting 2026 revenue of $240.8 million, for Core Gaming, implying a combined company valuation of $722.4 million (3x) to $963.2 million (4x), as Core Gaming's peers command a 3x-5x EV/Sales range.
The Value of Monthly Active Users (MAUs)
Adjust's Navigatingthe Mobile Gaming Landscape (2024) report highlights that in 2023, the global average ARPMAU across all mobile gaming subcategories was $0.77. Notably, Role-Playing Games (RPGs) generated the highest ARPMAU at $5.12, while adventure games earned $3.69 per MAU. The U.S. had the highest ARPMAU at $1.25, which is 62% above the global average.
According to the Udonis Mobile Gaming Market Statistics (2025) report, the average ARPU for mobile games in the U.S. is projected to be $60.58 in 2025, with expectations to reach $65 by 2029. This indicates a significant increase in user spending over time.
Please click here for a Deeper Dive on MAU Valuation Models, or insights from the ValueScope Report.
[ This image cannot be displayed. Please visit the source: https://images.newsfilecorp.com/files/10481/257271_core_gaming_logo.jpg ]
Core Gaming Logo
About Core Gaming
Core Gaming is an international AI-driven mobile games and applications developer headquartered in Miami, Florida. The company has developed and co-developed over 2,100 games, driven more than 780 million downloads, and reached more than 43 million monthly active users across 140 countries. Core's mission is to build globally scalable AI products that power entertainment, productivity, and creative expression.
For more information on Core Gaming's latest developments and offerings, visit www.coregaming.co.
Contact [email protected] for Analyst Report coverage and other investor/public relations services.
For additional 247marketnews.com Siyata disclosure https://247marketnews.com/syta-siyata-mobile-update/
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
[email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/257271
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
a few seconds ago
- Business Wire
CHTR BREAKING NEWS: Charter Communications, Inc. 18% Stock Drop Results in Class Action -- Investors are Notified to Contact BFA Law by October 14 Class Action Deadline
NEW YORK--(BUSINESS WIRE)--Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Charter Communications, Inc. (NASDAQ: CHTR) and certain of the Company's senior executives for potential violations of the federal securities laws. Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Charter Communications, Inc. (NASDAQ: CHTR) for potential violations of the federal securities laws. Share If you invested in Charter, you are encouraged to obtain additional information by visiting: Investors have until October 14, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Charter securities. The case is pending in the U.S. District Court for the Southern District of New York and is captioned Sandoval v. Charter Communications, Inc., No. 1:25-cv-06747. Why Was Charter Sued Under the Federal Securities Laws? Charter is a leading broadband, or high-speed internet, connectivity company and cable operator. Charter participated in the FCC's Affordable Connectivity Program ('ACP'), which provided funding to Charter in exchange for subsidizing high-speed internet plans for low-income households. In June 2024, lack of federal funding caused the ACP to end, which led to customer declines at Charter. During the relevant period, Charter told investors that the Company was executing a plan to minimize and move beyond risks that the end of the ACP had on customer declines and earnings. The Company stated that it had 'managed the end of the affordable connectivity program successfully' and that '[t]he impact of the elimination of the ACP is now behind us.' As alleged, in truth, the impact from the ACP's elimination was not behind Charter as the Company continued to experience internet customer and revenue declines from the program's end. The Stock Declines as the Truth Is Revealed On July 25, 2025, Charter announced its second quarter 2025 financial results. The Company reported that total internet customers decreased by 117,000 during the quarter, which included approximately 50,000 disconnects related to the end of the ACP, nearly double from the prior quarter. On this news, the price of Charter stock declined $70.25 per share, or 18.4%, from a closing price of $380.00 per share on July 24, 2025, to $309.75 per share on July 25, 2025. Click here for more information: . What Can You Do? If you invested in Charter you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Why Bleichmar Fonti & Auld LLP? BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named 'Elite Trial Lawyers' by the National Law Journal, among the top '500 Leading Plaintiff Financial Lawyers' by Lawdragon, 'Titans of the Plaintiffs' Bar' by Law360 and 'SuperLawyers' by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd. For more information about BFA and its attorneys, please visit Attorney advertising. Past results do not guarantee future outcomes.
Business Wire
a few seconds ago
- Business Wire
Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer in the Unified Patent Court of the European Union
WATERTOWN, Mass.--(BUSINESS WIRE)-- Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and immunological diseases, announced today that it has filed suit in the Unified Patent Court (UPC) of the European Union against Pfizer Inc. and certain of its subsidiaries (action number 35071/2025), seeking a determination of liability for use and infringement of European Patent No. EP 4 051 265 (the '265 Patent) in the manufacture, use and sale of Pfizer's COVID-19 antiviral, Paxlovid™ (nirmatrelvir tablets; ritonavir tablets). This enforcement action targets Pfizer's activities in the 18 countries of the European Union that are presently participating in the UPC. The European Patent Office's recent grant of the '265 Patent to Enanta was published in the European Patent Bulletin today. The '265 Patent is based on Enanta's July 2020 patent application describing coronavirus protease inhibitors invented by Enanta scientists. The '265 Patent is the European counterpart of U.S. Patent No. 11,358,953 (the '953 Patent) involved in ongoing U.S. litigation between Enanta and Pfizer Inc. Under UPC procedures, a hearing on the infringement action is expected to occur within the UPC's published 12-month target, with the decision rendered within weeks thereafter. If the UPC determines there has been infringement, subsequent proceedings would be required to determine damages. All timelines remain subject to potential rights of appeal and other customary proceedings in European patent litigation. About Enanta Pharmaceuticals, Inc. Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs with an emphasis on indications in virology and immunology. Enanta's clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting key drivers of the type 2 immune response, including KIT and STAT6 inhibition. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing hepatitis C virus (HCV) infection and is sold by AbbVie in numerous countries under the tradenames MAVYRET ® (U.S.) and MAVIRET ® (ex-U.S.) (glecaprevir/pibrentasvir). A portion of Enanta's royalties from HCV products developed under its collaboration with AbbVie contribute ongoing funding to Enanta's operations. Please visit for more information. Forward Looking Statements Disclaimer This press release contains forward-looking statements, including statements with respect to Enanta's filing in the UPC of a suit against Pfizer Inc. and certain of its subsidiaries seeking a determination of liability for use and infringement of Enanta's patent and Enanta's expectations with respect to any further action with respect to such proceedings. Statements that are not historical facts are based on management's current expectations, estimates, forecasts and projections about Enanta's business and the industry in which it operates and management's beliefs and assumptions. The statements contained in this release are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed in such forward-looking statements. Important factors and risks that may affect actual results include: Enanta is competing to develop intellectual property in areas of small-molecule drug development that are highly competitive; issued patents, including those covering one or more of its product candidates, could be found invalid or unenforceable if challenged in court and could be costly to defend and be a distraction for Enanta's senior management and scientific personnel; intellectual property litigation may lead to unfavorable publicity that harms Enanta's reputation and causes the market price of its common stock to decline; and other risk factors described or referred to in 'Risk Factors' in Enanta's Form 10-K for the fiscal year ended September 30, 2024 and other periodic reports filed more recently with the Securities and Exchange Commission. Enanta cautions investors not to place undue reliance on the forward-looking statements contained in this release. These statements speak only as of the date of this release, and Enanta undertakes no obligation to update or revise these statements, except as may be required by law.
Business Wire
a few seconds ago
- Business Wire
Stratasys Announces 2025 Annual General Meeting of Shareholders
MINNETONKA, Minn. & REHOVOT, Israel--(BUSINESS WIRE)--Stratasys Ltd. (Nasdaq: SSYS) (' Stratasys ' or the ' Company ') today announced that it will hold its 2025 Annual General Meeting of Shareholders (the ' Meeting ') on Tuesday, September 30, 2025, at 3:00 p.m. Israel time, at Meitar Law Offices, 16 Abba Hillel Road, 10 th floor, Ramat Gan 5250608, Israel. The record date for shareholders entitled to vote at the Meeting is Wednesday, August 20, 2025. The agenda for the Meeting is as follows: Re-election of each of Messrs. Yuval Cohen, S. Scott Crump, Aris Kekedjian, John J. McEleney, Dov Ofer, David Reis and Yair Seroussi, and Ms. Adina Shorr, collectively constituting the Company's director nominees, to serve as a director of the Company until the Company's next annual general meeting of shareholders and until the due election and qualification of his or her successor, or until his or her earlier resignation, replacement or removal. Approval of an amended compensation package for Mr. Yoav Zeif, the Company's Chief Executive Officer. Reappointment of Kesselman & Kesselman, a member of PricewaterhouseCoopers International Limited, as the Company's independent auditors for the year ending December 31, 2025 and for the additional period until the Company's next annual general meeting of shareholders, and authorization of the Board (upon recommendation of the audit committee of the Board) to fix their remuneration. Stratasys' Board recommends that Stratasys' shareholders vote in favor of each of the above proposals. The affirmative vote of the holders of a majority of the voting power represented at the Meeting in person or by proxy and voting thereon (which excludes abstentions and broker non-votes) is necessary for the approval of each of the proposals. Under the Israeli Companies Law, 5759-1999 (the ' Companies Law '), the approval of Proposal 2 is also subject to satisfaction of one of the following additional voting requirements: • the majority voted in favor of the proposal must include a majority of the shares held by non-controlling shareholders who do not have a conflict of interest (referred to in the Companies Law as a 'personal interest') in the approval of the proposal that are voted at the Meeting, excluding abstentions; or • the total number of shares held by non-controlling, non-conflicted shareholders (as described in the previous bullet-point) voted against the proposal must not exceed two percent (2%) of the aggregate voting rights in the Company. For purposes of the above special voting requirements, to the best of our knowledge, there are no shareholders who would be deemed 'controlling shareholders' of the Company under the Companies Law. In addition to the foregoing proposals, at the Meeting, the audited, consolidated financial statements of Stratasys for the annual period ended December 31, 2024 will be presented to, and considered by, Stratasys' shareholders (which will not involve a vote). Whether or not you attend the Meeting, your vote is important. Accordingly, you are asked to participate and vote regardless of the number of ordinary shares you own. Additional Information Concerning the Annual General Meeting and Where to Find It In connection with the Meeting, Stratasys will send to its shareholders a proxy statement describing in detail the proposals to be addressed at the Meeting and providing additional logistical information related to the Meeting, the procedure for voting by proxy, and various other information related to the Meeting, along with a proxy card or voting instruction form enabling Stratasys' shareholders to indicate their vote on each matter or instruct their brokers or other nominees how to vote on each matter (as applicable). The Company will also furnish copies of the proxy statement and a related proxy card to the Securities and Exchange Commission (the ' SEC ') in a Report of Foreign Private Issuer on Form 6-K, which may be obtained for free from the SEC's website at or the Company's website at or by directing such request to the Company's Chief Communications Officer and VP, Investor Relations, Yonah Lloyd, at the email address provided below. This press release is also available on the Stratasys website at In order to vote, if you are a record shareholder or a street holder (i.e., you hold your shares through a bank, broker or other nominee) and receive a physical proxy card or voting instruction form, respectively, you may complete and sign it and send it in to Broadridge, our agent for tallying the votes for the Meeting, in the envelope to be enclosed, Whether you are a record shareholder or a street holder, you may also vote or provide voting instructions to your bank, broker or nominee online (at or via telephone, In all such cases, your vote must be received by 11:59 p.m., Eastern time, on Monday, September 29, 2025. If you are a record shareholder and send in your proxy card directly to our registered Israeli office, it must be received at least four hours prior to the appointed time for the Meeting (i.e., 11:00 a.m., Israel time, on Tuesday, September 30, 2025). The final day on which notice may be submitted to Stratasys pursuant to Section 66(b) of the Companies Law and Section 5A(a) of the Companies Regulations (Notices and Announcements of General Meetings and Class Meetings in Public Companies and Additions of Agenda Items, 5760-2000) promulgated thereunder, shall be August 27, 2025. Any shareholder submitting such a notice should send it to the Company's Israeli offices, 1 Holtzman Street, Science Park, P.O. Box 2496, Rehovot 76124, Israel, Attention: Chief Legal Officer, Ms. Vered Ben-Jacob, email: To the extent that the Board determines to amend the notice of the Meeting as a result of any such submission, the Company will publish an updated notice with respect to the Meeting, no later than September 3, 2025, to be furnished to the SEC under cover of a Report of Foreign Private Issuer on Form 6-K. Participants in the Solicitation Stratasys and certain of its directors and executive officers may be deemed to be participants in the solicitation of proxies in respect of the Meeting. Information about the directors and executive officers of Stratasys, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in Stratasys' Annual Report on Form 20-F for the fiscal year ended December 31, 2024, which was filed with the SEC on March 6, 2025. You may obtain free copies of that document from Stratasys using the sources indicated above. About Stratasys Ltd. Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products, and healthcare. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world's leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care. To learn more about Stratasys, visit the Stratasys blog, (formerly Twitter), LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including the Company's websites, to share material, non-public information pursuant to the SEC's Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings. Stratasys is a registered trademark and the Stratasys signet is a trademark of Stratasys Ltd. and/or its subsidiaries or affiliates. All other trademarks are the property of their respective owners.
